The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Falk Pharma; Incyte
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Roche
Perioperative or adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Updated final results of the randomized phase II AIO-NEONAX trial.
 
Thomas Jens Ettrich
Consulting or Advisory Role - AstraZeneca; Bayer; BMS GmbH & Co. KG; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Eisai; Incyte; Ipsen; Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen
 
Waldemar Uhl
No Relationships to Disclose
 
Marko Kornmann
No Relationships to Disclose
 
Hana Algül
Consulting or Advisory Role - AstraZeneca; MSD; SERVIER
Speakers' Bureau - AstraZeneca; Seagen
Research Funding - Chugai Pharma
 
Helmut Friess
Stock and Other Ownership Interests - Bayer; Merck; Pfizer
Consulting or Advisory Role - Mylan
Expert Testimony - Mylan
 
Alexander Koenig
Honoraria - IPSEN; Pierre Fabre
Consulting or Advisory Role - Roche Pharma AG
 
Eike Gallmeier
No Relationships to Disclose
 
Manfred P. Lutz
Research Funding - SERVIER (Inst)
 
Kai Wille
No Relationships to Disclose
 
Carl Christoph Schimanski
Employment - Merck KGaA (I)
Research Funding - Merck KGaA (Inst)
 
Volker Kunzmann
No Relationships to Disclose
 
Michael Geissler
Consulting or Advisory Role - Amgen; Lilly; Merck
 
Dirk Waldschmidt
No Relationships to Disclose
 
Severin Daum
No Relationships to Disclose
 
Lisa Blome
No Relationships to Disclose
 
Andrea Tannapfel
Honoraria - Amgen; Falk Pharma; Merck; Pfizer
 
Lukas Perkhofer
Consulting or Advisory Role - AstraZeneca; SERVIER
Research Funding - SERVIER (Inst)
 
Margaret A. Tempero
Honoraria - CPRIT; Novartis
Consulting or Advisory Role - Abbvie; Advance Medical/Teladoc Health; AstraZeneca; Bristol-Myers Squibb; EcoR1 Capital; Eisai; Elicio Therapeutics; FibroGen; GlaxoSmithKline; Immunovia; Ipsen; Karyopharm Therapeutics; Merck; Pharmacyclics; Swedish Orphan Biovitrum
Research Funding - Bristol-Myers Squibb/Ono Pharmaceutical; Celgene; Halozyme; Pharmacyclics
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; BIOPHARM; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Merck; Pharmacyclics; Pharmacyte Biotech; Tocagen
 
Anke C. Reinacher-Schick
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MCI Group; Merck Serono; MSD; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Pierre Fabre; Roche
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); BioNTech (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Ipsen (Inst); Lilly (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Roche
 
Thomas Seufferlein
Honoraria - Amgen; AstraZeneca; Bayer Schering Pharma; BMS GmbH & Co. KG; Falk Foundation; Pierre Fabre; SERVIER
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Cantargia AB; Pierre Fabre; SERVIER
Research Funding - Celgene; Sanofi
Travel, Accommodations, Expenses - Celgene; Merck Serono; Roche; Sanofi; SERVIER